73 related articles for article (PubMed ID: 2709674)
1. Iron status in patients receiving erythropoietin for dialysis-associated anemia.
Van Wyck DB; Stivelman JC; Ruiz J; Kirlin LF; Katz MA; Ogden DA
Kidney Int; 1989 Feb; 35(2):712-6. PubMed ID: 2709674
[TBL] [Abstract][Full Text] [Related]
2. Author Correction: Effect of recombinant human erythropoietin combined with iron sucrose on postoperative hemoglobin in patients undergoing artificial joint replacement.
Yu W; Liu C; Bi Z
Sci Rep; 2023 Dec; 13(1):23105. PubMed ID: 38158417
[No Abstract] [Full Text] [Related]
3. Unmet needs about iron deficiency in peritoneal dialysis: a Delphi consensus panel.
Mazzaferro S; D'Alonzo S; Morosetti M
BMC Nephrol; 2022 Oct; 23(1):336. PubMed ID: 36266621
[TBL] [Abstract][Full Text] [Related]
4. The Role of Reticulocyte Hemoglobin Content for the Diagnosis of Functional Iron Deficiency in Hemodialyzed patients.
Alageeli AA; Alqahtany FS; Algahtani FH
Saudi J Biol Sci; 2021 Jan; 28(1):50-54. PubMed ID: 33424282
[TBL] [Abstract][Full Text] [Related]
5. Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.
Eisenga MF; Emans ME; van der Putten K; Cramer MJ; Diepenbroek A; Velthuis BK; Doevendans PA; Verhaar MC; Joles JA; Bakker SJL; Nolte IM; Braam B; Gaillard CAJM
J Am Heart Assoc; 2019 Aug; 8(16):e011130. PubMed ID: 31423921
[TBL] [Abstract][Full Text] [Related]
6. Molecular perspective of iron uptake, related diseases, and treatments.
Shokrgozar N; Golafshan HA
Blood Res; 2019 Mar; 54(1):10-16. PubMed ID: 30956958
[TBL] [Abstract][Full Text] [Related]
7. Elevated Neutrophil Gelatinase Lipocalin Levels Are Associated With Increased Oxidative Stress in Hemodialysis Patients.
Nevo A; Armaly Z; Abd El Kadir A; Douvdevani A; Tovbin D
J Clin Med Res; 2018 Jun; 10(6):461-465. PubMed ID: 29707087
[TBL] [Abstract][Full Text] [Related]
8. Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.
Hsiao PJ; Chan JS; Wu KL; Chiang WF; Huang JS; Wu CC; Chu P; Chen JS
J Res Med Sci; 2016; 21():99. PubMed ID: 28163745
[TBL] [Abstract][Full Text] [Related]
9. Iron Indices in Patients with Functional Anemia in Chronic Kidney Disease.
Reddy GC; Devaki R; Rao P
EJIFCC; 2013 Feb; 24(3):129-36. PubMed ID: 27683448
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life.
García-López S; Bocos JM; Gisbert JP; Bajador E; Chaparro M; Castaño C; García-Erce JA; Gomollón F
Blood Transfus; 2016 May; 14(2):199-205. PubMed ID: 27177405
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.
Karaboyas A; Zee J; Morgenstern H; Nolen JG; Hakim R; Kalantar-Zadeh K; Zager P; Pisoni RL; Port FK; Robinson BM
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1814-21. PubMed ID: 26286925
[TBL] [Abstract][Full Text] [Related]
12. Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients.
Eguchi A; Mochizuki T; Tsukada M; Kataoka K; Hamaguchi Y; Oguni S; Nitta K; Tsuchiya K
Int J Nephrol; 2012; 2012():239476. PubMed ID: 23193472
[TBL] [Abstract][Full Text] [Related]
13. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
Fishbane S; Pollack S; Feldman HI; Joffe MM
Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
[TBL] [Abstract][Full Text] [Related]
14. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2007; 39(3):935-40. PubMed ID: 17534732
[TBL] [Abstract][Full Text] [Related]
15. Iron therapy in the pediatric hemodialysis population.
Warady BA; Kausz A; Lerner G; Brewer ED; Chadha V; Brugnara C; Dahl NV; Watkins SL
Pediatr Nephrol; 2004 Jun; 19(6):655-61. PubMed ID: 15064942
[TBL] [Abstract][Full Text] [Related]
16. Intermittent versus maintenance iron therapy in children on hemodialysis: a randomized study.
Ruiz-Jaramillo Mde L; Guízar-Mendoza JM; Gutiérrez-Navarro Mde J; Dubey-Ortega LA; Amador-Licona N
Pediatr Nephrol; 2004 Jan; 19(1):77-81. PubMed ID: 14634860
[TBL] [Abstract][Full Text] [Related]
17. The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis.
Kim JK; Park BS; Park MJ; Choi W; Ma SK; Nah MY; Yeum CH; Jung K; Lee SC; Kim SW; Kim NH; Kang YJ; Choi KC
Korean J Intern Med; 2001 Jun; 16(2):110-7. PubMed ID: 11590897
[TBL] [Abstract][Full Text] [Related]
18. Costs of epoetin in patients with AIDS.
Henry DH
Pharmacoeconomics; 1994 May; 5(5):446-7. PubMed ID: 10147234
[No Abstract] [Full Text] [Related]
19. A cost-effectiveness analysis of epoetin usage for patients with AIDS.
Cantor SB; Carson RW; Spann SJ
Pharmacoeconomics; 1993 Mar; 3(3):244-9. PubMed ID: 10146947
[TBL] [Abstract][Full Text] [Related]
20. A serial study of the erythropoietic response to thermal injury.
Deitch EA; Sittig KM
Ann Surg; 1993 Mar; 217(3):293-9. PubMed ID: 8452408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
